Holen Sie sich die Stockscreener-App
1.29
6.52%
-0.09
Handel nachbörslich:
1.26
-0.03
-2.33%
Finanzdaten der Ernexa Therapeutics Inc-Aktie (ERNA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
100.00%
-
|
0.001 | 0.487 | -0.048 | 0.047 |
| Operating Expenses |
1.19%
2.73
|
2.698 | 2.806 | 4.883 | 5.773 |
| Depreciation and Amortization |
0.10
|
- | - | - | - |
| Operating Income/Loss |
1.22%
-2.73
|
-2.697 | -2.259 | -4.931 | -5.787 |
| Nonoperating Income/Loss |
79.09%
-5.464
|
-3.051 | -24.33 | -0.595 | -0.856 |
| Income/Loss From Continuing Operations Before Tax |
42.55%
-8.194
|
-5.748 | -26.59 | -5.526 | -6.643 |
| Income Tax Expense/Benefit |
27.27%
0.008
|
0.011 | 0.012 | 0.003 | 0.004 |
| Income/Loss From Continuing Operations After Tax |
42.42%
-8.202
|
-5.759 | -26.60 | -5.529 | -6.647 |
Net Income/Loss
|
42.42%
-8.202
|
-5.759 | -26.60 | -5.529 | -6.647 |
| Preferred Stock Dividends And Other Adjustments |
100.00%
-
|
0.008 | - | 0.008 | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
547.82%
53.36
|
8.237 | 5.41 | 5.41 | 5.41 |
| Diluted Average Shares |
547.82%
53.36
|
8.237 | 5.41 | 5.41 | 5.41 |
| Basic Earnings Per Share |
103.84%
-0.15
|
3.91 | -4.92 | -1.02 | -1.23 |
| Diluted Earnings Per Share |
103.84%
-0.15
|
3.91 | -4.92 | -1.02 | -1.23 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
100.00%
-
|
0.008 | - | 0.008 | - |
0.93%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):